NCI Definition: A histologically benign tumor, usually cystic with a vascular mural nodule, that is most often found in the cerebellum though it has been reported at other sites within the neuraxis. It is associated with von Hippel-Lindau disease (VHL gene located on chr 3p25-26). 
There is 1 clinical trial for cerebellar hemangioblastoma, of which 0 are open and 1 is completed or closed. Of the trial that contains cerebellar hemangioblastoma as an inclusion criterion, 1 is phase 1/phase 2 (0 open).
VHL is the most frequent gene inclusion criterion for cerebellar hemangioblastoma clinical trials .
Significant Genes in Cerebellar Hemangioblastoma
VHL is an inclusion eligibility criterion in 1 clinical trial for cerebellar hemangioblastoma, of which 0 are open and 1 is closed. Of the trial that contains VHL status and cerebellar hemangioblastoma as inclusion criteria, 1 is phase 1/phase 2 (0 open) .
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.